Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Pretreatment with atorvastatin ameliorates cobra venom factor-induced acute lung inflammation in mice

Fig. 3

ATR reduced the cell counts in the BALF and inhibited neutrophil infiltration in the lung tissues following CVF challenge. The cell counts were assessed with a hemocytometer. The superior lobe of the right lung was excised to detect the lung MPO activity 1 h after the CVF challenge. a Total cells in the BALF. b Lung MPO activity. Results are presented as mean ± SEM (n = 8 in each group). #P < 0.05 vs. the control group; ##P < 0.01 vs. the control group; **P < 0.01 vs. the CVF group. ATR, atorvastatin; BALF, bronchoalveolar lavage fluid; ASA, aspirin; CVF, cobra venom factor; MPO, myeloperoxidase; SEM, standard error of the mean

Back to article page